These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 7671248

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Modulation of transferrin receptor expression by inhibitors of nucleic acid synthesis.
    Hedley D, Rugg C, Musgrove E, Taylor I.
    J Cell Physiol; 1985 Jul; 124(1):61-6. PubMed ID: 2413049
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene.
    Yang DC, Jiang XP, Elliott RL, Head JF.
    Anticancer Res; 2001 Jul; 21(3B):1777-87. PubMed ID: 11497259
    [Abstract] [Full Text] [Related]

  • 4. Chloramphenicol-induced mitochondrial dysfunction is associated with decreased transferrin receptor expression and ferritin synthesis in K562 cells and is unrelated to IRE-IRP interactions.
    Leiter LM, Thatte HS, Okafor C, Marks PW, Golan DE, Bridges KR.
    J Cell Physiol; 1999 Sep; 180(3):334-44. PubMed ID: 10430173
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis.
    Nandy P, Lien EJ, Avramis VI.
    Anticancer Res; 1999 Sep; 19(3A):1625-33. PubMed ID: 10470093
    [Abstract] [Full Text] [Related]

  • 6. Synergistic inhibition of T-lymphoblastic leukemic CCRF-CEM cell growth by gallium and recombinant human alpha-interferon through action on cellular iron uptake.
    Chitambar CR, Wereley JP, Riaz-ul-Haq.
    Cancer Res; 1994 Jun 15; 54(12):3224-8. PubMed ID: 8205543
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of malignant cell growth by 311, a novel iron chelator of the pyridoxal isonicotinoyl hydrazone class: effect on the R2 subunit of ribonucleotide reductase.
    Green DA, Antholine WE, Wong SJ, Richardson DR, Chitambar CR.
    Clin Cancer Res; 2001 Nov 15; 7(11):3574-9. PubMed ID: 11705879
    [Abstract] [Full Text] [Related]

  • 8. Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer.
    Yang DC, Wang F, Elliott RL, Head JF.
    Anticancer Res; 2001 Nov 15; 21(1B):541-9. PubMed ID: 11299801
    [Abstract] [Full Text] [Related]

  • 9. Gene expression of iron-related proteins during iron deficiency caused by scurvy in guinea pigs.
    Gosiewska A, Mahmoodian F, Peterkofsky B.
    Arch Biochem Biophys; 1996 Jan 15; 325(2):295-303. PubMed ID: 8561510
    [Abstract] [Full Text] [Related]

  • 10. Lack of coordinate control of ferritin and transferrin receptor expression during rat liver regeneration.
    Cairo G, Tacchini L, Pietrangelo A.
    Hepatology; 1998 Jul 15; 28(1):173-8. PubMed ID: 9657110
    [Abstract] [Full Text] [Related]

  • 11. The transferrin receptor.
    Testa U, Pelosi E, Peschle C.
    Crit Rev Oncog; 1993 Jul 15; 4(3):241-76. PubMed ID: 8485201
    [Abstract] [Full Text] [Related]

  • 12. Iron regulation of ferritin gene expression.
    Munro HN.
    J Cell Biochem; 1990 Oct 15; 44(2):107-15. PubMed ID: 2123493
    [Abstract] [Full Text] [Related]

  • 13. Function and regulation of transferrin and ferritin.
    Ponka P, Beaumont C, Richardson DR.
    Semin Hematol; 1998 Jan 15; 35(1):35-54. PubMed ID: 9460808
    [Abstract] [Full Text] [Related]

  • 14. The influence of the base-paired flanking region on structure and function of the ferritin mRNA iron regulatory element.
    Dix DJ, Lin PN, McKenzie AR, Walden WE, Theil EC.
    J Mol Biol; 1993 May 20; 231(2):230-40. PubMed ID: 7685392
    [Abstract] [Full Text] [Related]

  • 15. Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects.
    White S, Taetle R, Seligman PA, Rutherford M, Trowbridge IS.
    Cancer Res; 1990 Oct 01; 50(19):6295-301. PubMed ID: 2400993
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of heme synthesis decreases transferrin receptor expression in mouse erythroleukemia cells.
    Hradilek A, Fuchs O, Neuwirt J.
    J Cell Physiol; 1992 Feb 01; 150(2):327-33. PubMed ID: 1734036
    [Abstract] [Full Text] [Related]

  • 17. Nitric oxide reduces nontransferrin-bound iron transport in HepG2 cells.
    Barisani D, Cairo G, Ginelli E, Marozzi A, Conte D.
    Hepatology; 1999 Feb 01; 29(2):464-70. PubMed ID: 9918923
    [Abstract] [Full Text] [Related]

  • 18. Transferrin receptor gene expression and transferrin-bound iron uptake are increased during postischemic rat liver reperfusion.
    Tacchini L, Fusar Poli D, Bernelli-Zazzera A, Cairo G.
    Hepatology; 2002 Jul 01; 36(1):103-11. PubMed ID: 12085354
    [Abstract] [Full Text] [Related]

  • 19. The IRE (iron regulatory element) family: structures which regulate mRNA translation or stability.
    Theil EC.
    Biofactors; 1993 May 01; 4(2):87-93. PubMed ID: 8347279
    [Abstract] [Full Text] [Related]

  • 20. Iron regulatory protein-independent regulation of ferritin synthesis by nitrogen monoxide.
    Mikhael M, Kim SF, Schranzhofer M, Soe-Lin S, Sheftel AD, Mullner EW, Ponka P.
    FEBS J; 2006 Aug 01; 273(16):3828-36. PubMed ID: 16911529
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.